Recent years have seen a number of exciting developments in the evolving and expanding role of somatostatin and its analog, octreotide, in the diagnosis and treatment of cancer. It is now clear that octreotide has potential applications not just in imaging, but also in medical therapy and radiotherapy. This book contains the papers from a symposium held in September 2001 in Noordwijk in The Netherlands where all of these varied aspects of the expanding role of octreotide in clinical oncology were discussed.

Contributors include leading researchers from North America and Europe, such as: PA Abrahamsson (Lund University Hospital, Sweden), EP Krenning (University Hospital Rotterdam, The Netherlands), AP Allgaier (University Hospital Freiburg, Germany), RJ Jensen (NIH/NIDDK/DDB, USA) and J Waxman (Imperial College School of Medicine, London, UK).

Sections
Cancer, Gastroenteropancreatic tumors, Primary liver tumors, Radiotherapy with Octreo Ther, Palliative use of sandostatin, Neuroendocrine differentiation of prostate cancer, The development of a new somatostatin analog